Shihua Luo

ORCID: 0000-0003-4926-144X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Integrated Energy Systems Optimization
  • Liver Disease and Transplantation
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Environmental Impact and Sustainability
  • Energy Load and Power Forecasting
  • Long-Term Effects of COVID-19
  • Organ Transplantation Techniques and Outcomes
  • Climate Change Policy and Economics
  • Electric Power System Optimization
  • RNA modifications and cancer
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 diagnosis using AI
  • Water-Energy-Food Nexus Studies
  • Cancer, Hypoxia, and Metabolism
  • Stock Market Forecasting Methods
  • Smart Grid Energy Management
  • Energy and Environment Impacts
  • Epigenetics and DNA Methylation
  • Biological and pharmacological studies of plants
  • Hybrid Renewable Energy Systems
  • Virus-based gene therapy research
  • Global Energy Security and Policy
  • Radiomics and Machine Learning in Medical Imaging
  • Carbon Dioxide Capture Technologies

First Affiliated Hospital of Jiangxi Medical College
2025

Jiangxi Provincial People's Hospital
2025

First Affiliated Hospital of University of South China
2025

University of South China
2025

Yunnan Provincial Hospital of Traditional Chinese Medicine
2018-2024

Yunnan University
2024

University of Electronic Science and Technology of China
2018-2024

Changsha University of Science and Technology
2024

Affiliated Hospital of Youjiang Medical University for Nationalities
2023-2024

Guangzhou Medical University
2023

In late December 2019, a cluster of patients with pneumonia unknown cause was linked epidemiologically to seafood and wet animal wholesale market in Wuhan City, China. The causative pathogen subsequently identified as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1Emerging understandings 2019-nCoV.Lancet. 2020; 135: 311Google Scholar Over course current pandemic, it became apparent that some can present abdominal symptoms without fever or manifestations, could be...

10.1016/j.cgh.2020.03.043 article EN other-oa Clinical Gastroenterology and Hepatology 2020-03-20

Nowadays, emission reduction becomes the main direction of energy system development. Replacing fossil fuel with renewable in sectors such as power and transport sector serves one essential measures. However, scientific gaps appear how this transition can be reached an system, including under goal “carbon neutral” China towards 2060. Taking Sichuan province example, study establishes pathways evaluates feasibility different technologies two sectors. Three scenarios based on various...

10.1016/j.egyr.2022.02.213 article EN cc-by-nc-nd Energy Reports 2022-03-10

BACKGROUND Transjugular intrahepatic portosystemic shunt (TIPS) has an important role in the therapy of complications portal-hypertension-related ascites. Various guidelines now indicate that TIPS is indicated for refractory ascites (RA), but recurrent nonrefractory (RNRA) achieved better clinical results. AIM To compare outcomes RA and RNRA patients with related to portal hypertension. METHODS There were 863 divided into two main categories who underwent between September 2016 2021. In...

10.4254/wjh.v17.i2.100451 article EN World Journal of Hepatology 2025-02-20

Liver cirrhosis patients can develop various complications including bacteremia as the intestinal flora is heterologous. In those with low immunity, trauma, or following surgery, etc., body susceptible to concurrent systemic local infections. Under these circumstances, even minimally invasive treatment methods such interventional therapy like transjugular intrahepatic portosystemic shunt (TIPS) for liver also result in A male patient decompensated experienced multiple episodes of...

10.4329/wjr.v17.i2.101932 article EN World Journal of Radiology 2025-02-26

Transjugular intrahepatic portosystemic shunt (TIPS) is currently used for the treatment of complications portal hypertension. The incidence hepatic encephalopathy (HE) remains a problem in TIPS placement. It has been reported that right branch mainly receives superior mesenteric venous blood while left from splenic vein. We hypothesized targeted puncture vein would divert non-nutritive into shunt; therefore, during may reduce risk HE.To evaluate influence on HE.A retrospective analysis 1244...

10.3748/wjg.v25.i9.1088 article EN cc-by-nc World Journal of Gastroenterology 2019-03-07

Transjugular intrahepatic portosystemic shunt (TIPS) is placed important role in the therapy of complications portal hypertension, there still no suitable criterion for a reduction gradient (PSG), which can both reduce PSG and maximize clinical results minimize hepatic encephalopathy (HE).To compare outcomes incidence HE after one-third during TIPS patients with variceal bleeding refractory ascites.A total 1280 portal-hypertension-related ascites or who underwent from January 2016 to 2019...

10.3748/wjg.v29.i15.2336 article EN cc-by-nc World Journal of Gastroenterology 2023-04-14

There is a close relationship between cirrhosis and hepatocellular carcinoma (HCC). Transjugular intrahepatic portosystemic shunt (TIPS) has good clinical effect in treating the complication of portal hypertension. However, because risk postoperative liver failure, severe complications, low survival rate for HCC, TIPS contraindicated patients with hypertension cancer. We studied large cohort HCC who underwent recurrent variceal bleeding and/or ascites.To assess safety, efficacy, TIPS.Group A...

10.12998/wjcc.v7.i13.1599 article EN World Journal of Clinical Cases 2019-07-06

AIMTo evaluate the effect of initial stent position on transjugular intrahepatic portosystemic shunt (TIPS). METHODSWe studied 425 patients from January 2004 to 2015 with refractory ascites or variceal bleeding who required TIPS placement.Patients were randomly

10.3748/wjg.v23.i26.4779 article EN cc-by-nc World Journal of Gastroenterology 2017-01-01

Abstract Background and Aim Patients with 2019 novel coronavirus disease (COVID‐19) could present gastrointestinal symptoms without fever or respiratory manifestations, which be overlooked by health‐care providers. We aimed to evaluate the clinical characteristics of COVID‐19 in patients presenting initial symptoms. Methods evaluated all confirmed cases Zhongnan Hospital Wuhan University between January 10 February 29, 2020. divided these into two groups: (group A, n = 183) syndrome and/or...

10.1111/jgh.15199 article EN Journal of Gastroenterology and Hepatology 2020-07-28

Cervical cancer (CC) is a frequently occurring in women with high mortality rate. Despite improvements to therapeutic strategies, the survival outcome for patients CC remains poor. Therefore, present study aimed investigate molecular mechanism underlying inhibition involving microRNA (miR)‑140‑5p and flap structure‑specific endonuclease 1 (FEN1). Bioinformatics analysis was conducted, which identified that FEN1 associated cell cycle progression. Subsequently, 3'untranslated region reporter...

10.3892/mmr.2020.11552 article EN cc-by Molecular Medicine Reports 2020-09-30

Transjugular intrahepatic portosystemic shunt (TIPS) is widely accepted as an alternative to surgery for management of complications portal hypertension. TIPS has been used treat vein thrombosis (PVT) in many centers since the 1990s. Although good therapeutic effects on formation PVT, effect PVT stenting rarely reported. Patients with splenectomy and pericardial devascu-larization have a high incidence which can markedly affect stent patency increase risk recurrent symptoms associated...

10.12998/wjcc.v7.i17.2450 article EN World Journal of Clinical Cases 2019-09-06

Objective In view of the difficulty shortage new coronavirus nucleal acid test in early COVID-19 outbreak, to explore application value chest CT screening patients. Methods Retrospective analysis was performed on data patients with fever who received and during January 25, 2020 February 2, Zhongnan Hospital Wuhan University. A total 587 were enrolled, including 290 males 297 females, aged from 11.0 96.0 (51.3±17.1) years old. Take nucleic results as gold standard, sensitivity,...

10.3760/cma.j.cn112149-20200218-00187 article EN 2020-05-10
Coming Soon ...